Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.89% | -53.70% | 141.97% | -6.65% | 124.58% |
| Total Depreciation and Amortization | -1.45% | 0.00% | 0.22% | -0.66% | -0.82% |
| Total Amortization of Deferred Charges | 11.11% | 0.00% | 15.38% | 5.41% | -2.63% |
| Total Other Non-Cash Items | 361.34% | 96.39% | -3,577.54% | 70.61% | -62.55% |
| Change in Net Operating Assets | -13.62% | -240.85% | -38.45% | 500.33% | -497.39% |
| Cash from Operations | -32.55% | -48.19% | -18.87% | 78.70% | 42.65% |
| Capital Expenditure | -1,500.00% | 96.00% | -2,400.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.25% | -501.08% | -16.25% | -- | -- |
| Cash from Investing | 48.17% | -316.95% | -340.82% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.50% | 37.21% | 32.97% | 19.98% | -19,739.47% |
| Issuance of Common Stock | 391.43% | -72.87% | 186.67% | 350.00% | -67.74% |
| Repurchase of Common Stock | -- | -- | -4.94% | 26.27% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 101.90% | 47.56% | 29.29% | 20.98% | -38,146.67% |
| Foreign Exchange rate Adjustments | -171.43% | -193.33% | 161.48% | -123.02% | 5,400.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 349.40% | -16.33% | 68.06% | 72.66% | -356.09% |